RxSight anticipates $140M to $160M 2026 revenue as Alcon collaboration adds $30M to $40M

PartnershipPositive

AI Analysis

Summary

RxSight issued 2026 revenue guidance of $140M-$160M, with an Alcon collaboration expected to contribute $30M-$40M to revenue. The partnership expands RxSight's market opportunity through the Alcon relationship.

Financial Highlights

Revenue

$140M-$160M

Guidance

2026 revenue guidance: $140M-$160M with Alcon collaboration contributing $30M-$40M

Importance:6/10

Sentiment:

0.60

revenue guidancepartnershipcollaboration2026 outlook

Read the original article

Published by Seeking Alpha Healthcare on July 7, 2026 2:33 PM

Read Original